![Rodolphe Lilamand](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Mr. Rodolphe Lilamand specializes in investments in information technology.
Previously he was a consultant with Nodal Consultants for 3 years where he conducted over 20 missions as strategy and marketing consultant for innovative projects.
He started his career at Accenture as Management and information system analyst.
Mr. Lilamand graduated from the Ecole Centrale Paris and from the ESCP-EAP (master Degree in Marketing).
Eerdere bekende functies van Rodolphe Lilamand
Bedrijven | Functie | Einde |
---|---|---|
Auriga Partners SA
![]() Auriga Partners SA Investment ManagersFinance Auriga Partners SA (Auriga) is an independent, management-owned venture capital firm which was founded by Patrick Bamas, Jacques Chatain and Bernard Daugeras in 1998. Headquartered in Paris, the firm's core activity is enterprise creation. In addition to providing a network of contacts capable of accelerating internationalization, and furthering strategic partnerships and business deals, Auriga manages several seed and early-stage funds specializing in information technology and life sciences. | Private Equity Investor | 31-12-2012 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Auriga Partners SA
![]() Auriga Partners SA Investment ManagersFinance Auriga Partners SA (Auriga) is an independent, management-owned venture capital firm which was founded by Patrick Bamas, Jacques Chatain and Bernard Daugeras in 1998. Headquartered in Paris, the firm's core activity is enterprise creation. In addition to providing a network of contacts capable of accelerating internationalization, and furthering strategic partnerships and business deals, Auriga manages several seed and early-stage funds specializing in information technology and life sciences. | Finance |